JP2022008403A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022008403A5 JP2022008403A5 JP2021150116A JP2021150116A JP2022008403A5 JP 2022008403 A5 JP2022008403 A5 JP 2022008403A5 JP 2021150116 A JP2021150116 A JP 2021150116A JP 2021150116 A JP2021150116 A JP 2021150116A JP 2022008403 A5 JP2022008403 A5 JP 2022008403A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- volume
- weight
- mass
- vision
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 6
- 230000004438 eyesight Effects 0.000 claims 5
- 239000011780 sodium chloride Substances 0.000 claims 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 5
- 229960000999 sodium citrate dihydrate Drugs 0.000 claims 5
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims 4
- 239000004327 boric acid Substances 0.000 claims 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 3
- 208000001491 myopia Diseases 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 230000004304 visual acuity Effects 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- 238000000149 argon plasma sintering Methods 0.000 claims 1
- 230000004313 glare Effects 0.000 claims 1
- 230000004297 night vision Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024062082A JP2024096131A (ja) | 2018-04-24 | 2024-04-08 | 眼の状態の治療のためのピロカルピン塩酸塩の使用 |
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862662144P | 2018-04-24 | 2018-04-24 | |
| US62/662,144 | 2018-04-24 | ||
| US201862780117P | 2018-12-14 | 2018-12-14 | |
| US62/780,117 | 2018-12-14 | ||
| US201962790957P | 2019-01-10 | 2019-01-10 | |
| US62/790,957 | 2019-01-10 | ||
| JP2020559558A JP6946575B2 (ja) | 2018-04-24 | 2019-04-24 | 眼の状態の治療のためのピロカルピン塩酸塩の使用 |
| PCT/US2019/028917 WO2019209955A2 (en) | 2018-04-24 | 2019-04-24 | Presbyopia treatments |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020559558A Division JP6946575B2 (ja) | 2018-04-24 | 2019-04-24 | 眼の状態の治療のためのピロカルピン塩酸塩の使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024062082A Division JP2024096131A (ja) | 2018-04-24 | 2024-04-08 | 眼の状態の治療のためのピロカルピン塩酸塩の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022008403A JP2022008403A (ja) | 2022-01-13 |
| JP2022008403A5 true JP2022008403A5 (enExample) | 2022-05-06 |
| JP7470667B2 JP7470667B2 (ja) | 2024-04-18 |
Family
ID=66821312
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020559558A Active JP6946575B2 (ja) | 2018-04-24 | 2019-04-24 | 眼の状態の治療のためのピロカルピン塩酸塩の使用 |
| JP2021150116A Active JP7470667B2 (ja) | 2018-04-24 | 2021-09-15 | 眼の状態の治療のためのピロカルピン塩酸塩の使用 |
| JP2024062082A Pending JP2024096131A (ja) | 2018-04-24 | 2024-04-08 | 眼の状態の治療のためのピロカルピン塩酸塩の使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020559558A Active JP6946575B2 (ja) | 2018-04-24 | 2019-04-24 | 眼の状態の治療のためのピロカルピン塩酸塩の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024062082A Pending JP2024096131A (ja) | 2018-04-24 | 2024-04-08 | 眼の状態の治療のためのピロカルピン塩酸塩の使用 |
Country Status (25)
| Country | Link |
|---|---|
| US (4) | US10610518B2 (enExample) |
| EP (2) | EP4066830A1 (enExample) |
| JP (3) | JP6946575B2 (enExample) |
| KR (2) | KR20210005134A (enExample) |
| CN (1) | CN112272558A (enExample) |
| AU (3) | AU2019261598B9 (enExample) |
| BR (1) | BR112020021845A2 (enExample) |
| CA (2) | CA3162141A1 (enExample) |
| CL (1) | CL2020002734A1 (enExample) |
| CO (1) | CO2020014563A2 (enExample) |
| CY (1) | CY1125325T1 (enExample) |
| DK (1) | DK3681500T3 (enExample) |
| ES (1) | ES2920803T5 (enExample) |
| HR (1) | HRP20220762T1 (enExample) |
| HU (1) | HUE058931T2 (enExample) |
| IL (1) | IL278178A (enExample) |
| LT (1) | LT3681500T (enExample) |
| MX (1) | MX2020011301A (enExample) |
| PH (1) | PH12020551766A1 (enExample) |
| PL (1) | PL3681500T3 (enExample) |
| PT (1) | PT3681500T (enExample) |
| RS (1) | RS63360B1 (enExample) |
| SG (1) | SG11202010472XA (enExample) |
| SI (1) | SI3681500T1 (enExample) |
| WO (1) | WO2019209955A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102654048B1 (ko) | 2017-07-20 | 2024-04-03 | 세인다 파마슈티컬 광저우 코포레이션 | 근시 치료용 조성물 및 방법 |
| US20210251970A1 (en) | 2018-10-10 | 2021-08-19 | Presbyopia Therapies Inc | Compositions and methods for storage stable ophthalmic drugs |
| CN113164451A (zh) | 2018-10-15 | 2021-07-23 | 奥库菲尔制药股份有限公司 | 治疗青光眼的方法和组合物及相关病症 |
| EP3870170A4 (en) | 2018-10-26 | 2022-07-20 | Ocuphire Pharma, Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PRESBYOPIA, MYDRIASIS AND OTHER EYE DISEASES |
| AU2021338618B2 (en) * | 2020-09-11 | 2024-02-01 | Intratus-Nevada, Inc. | Compositions and methods for treating presbyopia, hyperopia, astigmatism, decreased stereopsis, and decreased contrast sensitivity |
| JP2024505517A (ja) * | 2021-01-28 | 2024-02-06 | グラウコス コーポレイション | 製剤 |
| WO2022232205A1 (en) * | 2021-04-28 | 2022-11-03 | Lenz Therapeutics, Inc. | A method of reducing brow ache |
| CN115368310B (zh) | 2021-05-18 | 2025-06-27 | 奥库菲尔医药公司 | 合成甲磺酸酚妥拉明的方法 |
| EP4433053A4 (en) | 2021-11-17 | 2025-09-17 | Lenz Therapeutics Operations Inc | ACECLIDINE DERIVATIVES, THEIR COMPOSITIONS AND METHODS OF USE |
| CN116350790B (zh) | 2021-12-28 | 2025-02-07 | 沈阳兴齐眼药股份有限公司 | 组合物及其在制备用于治疗老花眼的药物中的用途 |
| US20230270671A1 (en) * | 2022-01-14 | 2023-08-31 | Somerset Therapeutics, Llc | Pharmaceutically stable pilocarpine formulations with substantially reduced buffer content and related methods |
| US11969410B2 (en) | 2022-02-09 | 2024-04-30 | Somerset Therapeutics, Llc | Low pH pilocarpine and brimonidine compound formulations and related methods |
| CN119584954A (zh) | 2022-04-21 | 2025-03-07 | 格劳科斯公司 | 眼用局部乳膏组合物 |
| CN119546278A (zh) | 2022-05-18 | 2025-02-28 | 格劳科斯公司 | 两性离子在眼用局部乳膏组合物和制剂中的新应用 |
| CN117243888A (zh) * | 2023-09-22 | 2023-12-19 | 南京海纳制药有限公司 | 一种含有盐酸毛果芸香碱滴眼水性药物组合物及其制备方法 |
| US12414942B1 (en) | 2024-03-15 | 2025-09-16 | Lenz Therapeutics Operations, Inc. | Compositions, methods, and systems for treating presbyopia |
Family Cites Families (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4474751A (en) | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Ophthalmic drug delivery system utilizing thermosetting gels |
| US4851521A (en) | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| CA2003198C (en) | 1988-11-29 | 1995-03-21 | Anthony J. Dziabo, Jr. | Aqueous ophthalmic solutions and method for preserving same |
| US5122522A (en) | 1989-06-21 | 1992-06-16 | The Trustees Of The University Of Pennsylvania | Treatment and control of ocular development |
| US5055467A (en) | 1989-11-13 | 1991-10-08 | Allergan, Inc. | Pharmaceutical epinephrine-pilocarpine compounds |
| US5496471A (en) | 1990-01-08 | 1996-03-05 | Ciba-Geigy Corporation | Apparatus for removing components from solutions |
| US5776916A (en) | 1990-07-10 | 1998-07-07 | Gramer; Eugen | Medicament for reducing the intraocular pressure |
| JP2536806B2 (ja) | 1991-03-27 | 1996-09-25 | アルコン ラボラトリーズ インコーポレイテッド | ゲル化多糖類と微粉砕された薬剤担体とを組み合わせた局部眼科用組成物 |
| US5459133A (en) | 1992-06-05 | 1995-10-17 | Telor Ophthalmic Pharmaceuticals, Inc. | Methods and products for treating presbyopia |
| WO1994001096A1 (en) | 1992-07-02 | 1994-01-20 | Telor Ophthalmic Pharmaceuticals, Inc. | Methods and products for treating presbyopia |
| SE512871C2 (sv) | 1992-08-20 | 2000-05-29 | Santen Oy | Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension |
| AU5599594A (en) * | 1992-11-16 | 1994-06-08 | Ciba-Geigy Ag | Polyvinyl alcohol/borate ophthalmic drug delivery system |
| US5422116A (en) | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
| SE9401109D0 (sv) | 1994-03-31 | 1994-03-31 | Leiras Oy | Opthalmic composition II |
| US5574518A (en) | 1995-01-10 | 1996-11-12 | Les Laboratoires Opti-Centre Inc. | System incorporation two different sphero-non-spherical contact lenses for correcting presbytia |
| US5612027A (en) | 1995-04-18 | 1997-03-18 | Galin; Miles A. | Controlled release of miotic and mydriatic drugs in the anterior chamber |
| US6291466B1 (en) * | 1998-07-30 | 2001-09-18 | Allergan Sales, Inc. | Cholinergic agents in the treatment of presbyopia |
| US6164282A (en) | 1999-01-27 | 2000-12-26 | Allergan Sales, Inc. | Methods for restoring and/or enhancing accommodation in pseudo phakia |
| CH693625A5 (it) | 1999-02-18 | 2003-11-28 | Inpharma Sa | Composizioni farmaceutiche contenenti composti ad attività promotrice di assorbimento di principi attivi. |
| IT1306135B1 (it) * | 1999-04-26 | 2001-05-30 | Farmigea Spa | Composizioni oftalmiche per il trattamento delle turbe visivecaratterizzate da ridotta sensibilita' al contrasto. |
| US6420407B1 (en) | 1999-09-16 | 2002-07-16 | Gerald Horn | Ophthalmic formulation which modulates dilation |
| EP1214065A4 (en) | 1999-09-16 | 2009-01-07 | Ocularis Pharma Inc | METHOD USING THE ALPHA AGONIST TO OPTIMIZE THE SIZE OF THE PUPIL |
| TWI227143B (en) | 1999-12-15 | 2005-02-01 | Guo-Jiun Sung | In situ gel formation for ophthalmic delivery by combining Pluronic/Carbopol medic composition and its preparing method |
| US6218428B1 (en) | 2000-04-28 | 2001-04-17 | Emil Chynn | Ophthalmic composition |
| PE20020146A1 (es) | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
| AU2001291159A1 (en) | 2000-09-20 | 2002-04-02 | Shahinian Jr., Lee | Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications |
| US6273092B1 (en) | 2000-09-22 | 2001-08-14 | Gerard M. Nolan | Methods for treating various eye disorders |
| ITMI20010708A1 (it) | 2001-04-03 | 2002-10-03 | Alessandro Randazzo | Trattamento farmacologico degli aloni notturni e delle immagini fantasma con parasimpaticomimetici diluiti aceclidina/pilocarpina dopo inter |
| US20030139737A1 (en) | 2002-01-24 | 2003-07-24 | J.T. Lin | Method and apparatus for treatment of presbyopia by lens relaxation and anterior shift |
| ES2397574T3 (es) | 2002-07-30 | 2013-03-08 | Omeros Corporation | Procedimiento y soluciones de irrigación oftalmológica |
| US20050261641A1 (en) | 2002-09-26 | 2005-11-24 | Warchol Mark P | Method for ophthalmic administration of medicament |
| US20070211212A1 (en) | 2002-09-26 | 2007-09-13 | Percy Bennwik | Eye state sensor |
| US20040078009A1 (en) | 2002-10-17 | 2004-04-22 | Lin J. T. | Method and apparatus for the treatment of presbyopia and other eye disorders combining pharmocological and surgical means |
| US20050205101A1 (en) * | 2002-10-17 | 2005-09-22 | Lin J T | Combined pharmocological and surgical method and system for the treatment of eye disorders |
| US20060177430A1 (en) | 2002-12-20 | 2006-08-10 | Chakshu Research Inc | Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer |
| NZ540885A (en) | 2002-12-20 | 2009-02-28 | Chakshu Res Inc | Ophthalmic formulation for the prevention and treatment of ocular conditions |
| CA2517145C (en) | 2003-03-05 | 2017-08-01 | Halozyme, Inc. | Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| US20050119262A1 (en) | 2003-08-21 | 2005-06-02 | Pharmacia Corporation | Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent |
| JP4308255B2 (ja) | 2004-05-21 | 2009-08-05 | 千寿製薬株式会社 | ムスカリン受容体作動薬を含有する眼科用経皮吸収型製剤 |
| US20050279369A1 (en) | 2004-06-21 | 2005-12-22 | Lin J T | Method and apparatus for the treatment of presbyopia and glaucoma by ciliary body ablation |
| JP2008517671A (ja) | 2004-10-22 | 2008-05-29 | アキュフォーカス・インコーポレーテッド | 光学装置を目の軸に位置合わせするためのシステム及び方法 |
| BRPI0615432A2 (pt) | 2005-09-02 | 2011-05-17 | Theravida Inc | composição farmacêutica, e, uso de compostos |
| US8158152B2 (en) | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| CA2658394C (en) | 2006-07-12 | 2016-08-16 | University Of Tennessee Research Foundation | Substituted acylanilides and methods of use thereof |
| EP1938839B1 (en) | 2006-12-18 | 2009-08-19 | Jorge Luis Benozzi | Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia |
| BRPI0819081A8 (pt) | 2007-10-08 | 2016-08-30 | Fovea Pharmaceuticals Sa | Formulação oftálmica aquosa, processo para preparar a mesma, e, método para inibir, tratar ou prevenir doenças oculares e doença ou condição relacionada, em um paciente em necessidade de tal tratamento |
| GB0724558D0 (en) | 2007-12-15 | 2008-01-30 | Sharma Anant | Optical correction |
| AU2015202175A1 (en) | 2007-12-15 | 2015-05-14 | Anant Sharma | Optical correction |
| WO2010125416A1 (en) | 2009-04-27 | 2010-11-04 | Raouf Rekik | Drug delivery to the anterior and posterior segments of the eye |
| WO2010135731A1 (en) | 2009-05-22 | 2010-11-25 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
| US8299079B2 (en) | 2009-05-22 | 2012-10-30 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
| TW201109325A (en) | 2009-07-30 | 2011-03-16 | Wakamoto Pharma Co Ltd | Aqueous composition for eye drops |
| AR081049A1 (es) | 2010-08-17 | 2012-06-06 | Gonzalez Santos Alejandro Raul | Medicamento oftalmico para el tratamiento de la hipermetropia |
| US9119772B2 (en) * | 2011-01-26 | 2015-09-01 | Allergan, Inc. | Androgen composition for treating an opthalmic condition |
| BR112014006607A2 (pt) | 2011-09-20 | 2017-04-25 | Allergan Inc | composições e métodos para tratamento de presbiopia, hiperopia leve e astigmatismo irregular |
| KR20140103099A (ko) | 2011-10-12 | 2014-08-25 | 아센디스 파마 옵탈몰로지 디비젼 에이/에스 | 안구 병태의 예방 및 치료 |
| RU2014129268A (ru) | 2011-12-16 | 2016-02-10 | Аллерган, Инк. | Офтальмологические составы, которые содержат привитые сополимеры поливинилкапролактам-поливинилацетат-полиэтиленгликоля |
| EP2630952A1 (en) | 2012-02-23 | 2013-08-28 | Novagali Pharma S.A. | Self-preserved oil dispersions comprising boric acid |
| US10507245B2 (en) | 2012-07-19 | 2019-12-17 | Luis Felipe Vejarano Restrepo | Ophthalmic formulation and method for ameliorating presbyopia |
| EP2950800B1 (en) | 2013-02-01 | 2020-09-09 | Ocuphire Pharma, Inc. | Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance |
| CA2899339C (en) | 2013-02-01 | 2021-07-06 | Ocularis Pharma, Llc | Aqueous ophthalmic solutions of phentolamine and medical uses thereof |
| US9314427B2 (en) | 2013-08-28 | 2016-04-19 | Presbyopia Therapies Llc | Compositions and methods for the improvement of distance vision and the treatment of refractive errors of the eye |
| US9968594B2 (en) | 2013-08-28 | 2018-05-15 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
| US9089562B2 (en) | 2013-08-28 | 2015-07-28 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
| US8859623B1 (en) | 2013-11-14 | 2014-10-14 | Paragon BioTeck, Inc. | Methods and compositions of stable phenylephrine formulations |
| ES2538551B1 (es) | 2013-12-20 | 2016-01-13 | Eurocanarias Oftalmológica, Sl | Composición Oftálmica para la corrección de la presbicia |
| ES2834334T3 (es) | 2014-01-10 | 2021-06-17 | Santen Pharmaceutical Co Ltd | Preparación farmacéutica que incluye compuesto de ácido piridilaminoacético |
| CN106456584A (zh) | 2014-02-11 | 2017-02-22 | 阿拉西斯医药公司 | 用于矫正老视的药理学眼科用组合物和其施用 |
| US11052094B2 (en) | 2015-05-29 | 2021-07-06 | Sydnexis, Inc. | D2O stabilized pharmaceutical formulations |
| US20190000808A1 (en) | 2015-07-13 | 2019-01-03 | Allergan, Inc. | Composition and methods for the treatment of blephopharoptosis |
| CH711969A2 (it) | 2015-12-29 | 2017-06-30 | Pinelli Roberto | Composizione per il trattamento della presbiopia. |
| US10231968B2 (en) | 2016-08-01 | 2019-03-19 | David R. Hardten | Medicinal solution to be continuously or pulse-delivered to the eye for treating ophthalmological conditions/maladies |
| CN116726006A (zh) | 2016-08-19 | 2023-09-12 | 阿拉西斯医药公司 | 眼科药物组合物及其相关用途 |
| EP4241759A1 (en) | 2016-10-12 | 2023-09-13 | PS Therapy, Inc. | Artificial tear, contact lens and drug vehicle compositions and methods of use thereof |
-
2019
- 2019-04-24 KR KR1020207033656A patent/KR20210005134A/ko not_active Ceased
- 2019-04-24 HR HRP20220762TT patent/HRP20220762T1/hr unknown
- 2019-04-24 RS RS20220575A patent/RS63360B1/sr unknown
- 2019-04-24 SG SG11202010472XA patent/SG11202010472XA/en unknown
- 2019-04-24 ES ES19729883T patent/ES2920803T5/es active Active
- 2019-04-24 CA CA3162141A patent/CA3162141A1/en active Pending
- 2019-04-24 CN CN201980037652.3A patent/CN112272558A/zh active Pending
- 2019-04-24 MX MX2020011301A patent/MX2020011301A/es unknown
- 2019-04-24 PL PL19729883.9T patent/PL3681500T3/pl unknown
- 2019-04-24 AU AU2019261598A patent/AU2019261598B9/en not_active Ceased
- 2019-04-24 LT LTEPPCT/US2019/028917T patent/LT3681500T/lt unknown
- 2019-04-24 WO PCT/US2019/028917 patent/WO2019209955A2/en not_active Ceased
- 2019-04-24 EP EP22160205.5A patent/EP4066830A1/en active Pending
- 2019-04-24 SI SI201930260T patent/SI3681500T1/sl unknown
- 2019-04-24 JP JP2020559558A patent/JP6946575B2/ja active Active
- 2019-04-24 CA CA3074618A patent/CA3074618C/en active Active
- 2019-04-24 KR KR1020237017632A patent/KR20230079489A/ko active Pending
- 2019-04-24 PT PT197298839T patent/PT3681500T/pt unknown
- 2019-04-24 US US16/393,175 patent/US10610518B2/en active Active
- 2019-04-24 HU HUE19729883A patent/HUE058931T2/hu unknown
- 2019-04-24 DK DK19729883.9T patent/DK3681500T3/da active
- 2019-04-24 BR BR112020021845-6A patent/BR112020021845A2/pt not_active IP Right Cessation
- 2019-04-24 EP EP19729883.9A patent/EP3681500B2/en active Active
-
2020
- 2020-02-14 US US16/791,039 patent/US11285134B2/en active Active
- 2020-05-21 AU AU2020203311A patent/AU2020203311A1/en not_active Abandoned
- 2020-10-20 IL IL278178A patent/IL278178A/en unknown
- 2020-10-22 CL CL2020002734A patent/CL2020002734A1/es unknown
- 2020-10-23 PH PH12020551766A patent/PH12020551766A1/en unknown
- 2020-11-24 CO CONC2020/0014563A patent/CO2020014563A2/es unknown
-
2021
- 2021-09-15 JP JP2021150116A patent/JP7470667B2/ja active Active
-
2022
- 2022-01-12 US US17/647,813 patent/US20220241245A1/en not_active Abandoned
- 2022-02-18 AU AU2022201106A patent/AU2022201106A1/en not_active Abandoned
- 2022-06-22 CY CY20221100430T patent/CY1125325T1/el unknown
-
2024
- 2024-03-29 US US18/621,624 patent/US20240382462A1/en not_active Abandoned
- 2024-04-08 JP JP2024062082A patent/JP2024096131A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022008403A5 (enExample) | ||
| HRP20220762T1 (hr) | Upotreba pilokarpin-hidroklorida u liječenju prezbiopije | |
| JP2025176149A (ja) | アトロピン含有水性組成物 | |
| ES2461617T3 (es) | Composiciones farmacéuticas acuosas que contienen complejos borato-polioles | |
| WO2008011836A3 (es) | Soluciones oftálmicas | |
| ES2212131T3 (es) | Composiciones farmaceuticas con actividad antimicrobiana. | |
| RU2010150863A (ru) | Фармацевтическая композиция для лечения ушных заболеваний | |
| NZ600544A (en) | Compositions and methods for the treatment of angiogenesis-related eye diseases | |
| ATE511847T1 (de) | Pharmazeutische zubereitung für die behandlung entzündlicher erkrankungen des urogenitaltraktes | |
| NZ613291A (en) | Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof | |
| CH711969A2 (it) | Composizione per il trattamento della presbiopia. | |
| JP2021046394A5 (enExample) | ||
| CA2468664A1 (en) | Ketorolac tromethamine compositions for treating or preventing ocular pain | |
| JP6770436B2 (ja) | 高浸透圧ヒアルロン酸組成物 | |
| JP2009500397A5 (enExample) | ||
| JP2009500398A5 (enExample) | ||
| ES2754449T3 (es) | Acido carboxílico de pirrolidona (pca) para uso oftálmico | |
| CA2758858C (en) | Aqueous ophthalmic compositions containing anionic therapeutic agents | |
| RU2019118904A (ru) | Распределение в глазу и фармакокинетика композиций лифитеграста | |
| IL273213B1 (en) | Topical preparations of chloroprocaine | |
| US20180147140A1 (en) | Treatment and Prevention of ENT Infections | |
| MX2022006523A (es) | Composicion que comprende budesonida para uso oftalmico. | |
| BRPI0410576A (pt) | composto quìmico, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, método para o tratamento, prevenção ou alìvio de uma doença ou um distúrbio ou condição de um corpo de animal vivo | |
| CN101467963A (zh) | 治疗干眼病的眼药水 | |
| CN108348457A (zh) | 无菌水性眼用溶液的治疗用途 |